Is Sangamo Therapeutics Inc (SGMO) Stock Paving the Way for Earnings?

RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]

Sangamo Therapeutics Inc (SGMO) Stock is poised for a successful quarter

RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]

Recent trade makes Sangamo Therapeutics Inc (SGMO) Stock an appealing buy

RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]

Facts about Sangamo Therapeutics Inc (SGMO) Stock that you might not know

RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]

A positive surprise is on the way: Sangamo Therapeutics Inc (SGMO) Stock

RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. We previously noted in another research note published on April 28, 2023 by BofA Securities that downgraded the stock from a Neutral to […]

Sangamo Therapeutics Inc (SGMO) Stock: Thought Concerns

RBC Capital Mkts lowered the price target for the Sangamo Therapeutics Inc (NASDAQ:SGMO) stock from “an Outperform” to “a Sector perform”. The rating was released on November 03, 2023, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to […]